LOHOCLA RESEARCH CORPORATION
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.4Mattributed |
|---|---|
| Latest round | grant, $3.4M, 2024-01-01attributed |
| Founded | 2006 |
| Headquarters | AURORA, Colorado |
| Industry | bio |
| Stage | unknown |
| Website | lohocla.com |
Lohocla develops multi-target small-molecule drugs aimed at chronic pain, neuroinflammation, and addiction by modulating several neural pathways with a single compound. It targets patients underserved by current single-mechanism therapies. The multi-target design is positioned to improve both efficacy and safety profiles.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $3.4M | undisclosed |
Detected tech stack
PHP 8.4.19, Bootstrap 4.6.1, Apache HTTP Server, Google Analytics, Google Tag Manager, Popper 2.11.2, DoubleClick Floodlight, cdnjs, WordPress, Cloudflare, MySQL, jquery 1.9.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.4M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.4M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | lohocla.com, read 2026-05-05 |
| Description | self-reported | lohocla.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.